"Colitis, Ulcerative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
Descriptor ID |
D003093
|
MeSH Number(s) |
C06.405.205.265.231 C06.405.205.731.249 C06.405.469.158.188.231 C06.405.469.432.249
|
Concept/Terms |
Colitis, Ulcerative- Colitis, Ulcerative
- Idiopathic Proctocolitis
- Ulcerative Colitis
- Colitis Gravis
- Inflammatory Bowel Disease, Ulcerative Colitis Type
|
Below are MeSH descriptors whose meaning is more general than "Colitis, Ulcerative".
Below are MeSH descriptors whose meaning is more specific than "Colitis, Ulcerative".
This graph shows the total number of publications written about "Colitis, Ulcerative" by people in this website by year, and whether "Colitis, Ulcerative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 2 | 6 |
1995 | 8 | 0 | 8 |
1996 | 5 | 3 | 8 |
1997 | 3 | 0 | 3 |
1998 | 7 | 2 | 9 |
1999 | 4 | 2 | 6 |
2000 | 6 | 0 | 6 |
2001 | 8 | 2 | 10 |
2002 | 6 | 1 | 7 |
2003 | 11 | 1 | 12 |
2004 | 12 | 0 | 12 |
2005 | 6 | 4 | 10 |
2006 | 15 | 1 | 16 |
2007 | 12 | 4 | 16 |
2008 | 11 | 2 | 13 |
2009 | 10 | 3 | 13 |
2010 | 9 | 0 | 9 |
2011 | 22 | 3 | 25 |
2012 | 11 | 1 | 12 |
2013 | 13 | 2 | 15 |
2014 | 8 | 0 | 8 |
2015 | 7 | 4 | 11 |
2016 | 21 | 5 | 26 |
2017 | 17 | 4 | 21 |
2018 | 13 | 1 | 14 |
2019 | 19 | 4 | 23 |
2020 | 23 | 2 | 25 |
2021 | 25 | 1 | 26 |
2022 | 28 | 0 | 28 |
2023 | 20 | 0 | 20 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colitis, Ulcerative" by people in Profiles.
-
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension. J Crohns Colitis. 2024 Feb 26; 18(2):264-274.
-
A novel conjugative transposon carrying an autonomously amplified plasmid. mBio. 2024 Feb 14; 15(2):e0278723.
-
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis. J Crohns Colitis. 2023 Dec 30; 17(12):2012-2025.
-
Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center. Dig Dis Sci. 2024 Feb; 69(2):579-587.
-
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2023 Dec 05; 29(12):1997-1998.
-
A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index. J Crohns Colitis. 2023 Nov 24; 17(11):1733-1743.
-
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme. J Crohns Colitis. 2023 Nov 24; 17(11):1761-1770.
-
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data. Inflamm Bowel Dis. 2023 11 02; 29(11):1723-1729.
-
Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control study. Indian J Gastroenterol. 2024 Feb; 43(1):244-253.
-
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflamm Bowel Dis. 2023 09 01; 29(9):1370-1379.